Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Women with atrial fibrillation face a higher risk of ischemic stroke than men

13.09.2005


Women with atrial fibrillation who are not on anticoagulant therapy have a higher rate of ischemic stroke and face a higher absolute risk for stroke than do men with the condition, according to a joint study by researchers at the University of California, San Francisco, Massachusetts General Hospital, the Division of Research at Kaiser Permanente and Boston University School of Medicine.

Using a sample of 13,559 patients with atrial fibrillation, or rapid irregular contractions of the heart, researchers compared the rates of ischemic stroke between men and women and examined the efficacy and complications associated with a common blood thinner, Warfarin. Their findings are being reported in the September 20 issue of Circulation.

Warfarin is well known to be effective in reducing the risk of stroke in persons with atrial fibrillation; however prior studies have provided conflicting evidence about whether women with atrial fibrillation have a higher risk for stroke than men when not taking blood thinners. "The research from this study clearly shows that gender plays a role in ischemic stroke risk and occurrence," said lead author Margaret Fang, MD, MPH, assistant adjunct professor of medicine, and hospitalist at UCSF Medical Center.



The higher incidence of stroke in women not taking Warfarin therapy occurred among women in all stroke-risk-factor categories, including those with prior stroke, hypertension, congestive heart failure, coronary artery disease and diabetes. Because of the significant differences in the rate of stroke between men and women, the study indicates that being a woman is an independent risk factor for stroke and should be considered when choosing treatment options for women with atrial fibrillation.

According to the researchers, atrial fibrillation is the most common cardiac arrhythmia, and a major risk factor for both ischemic stroke and peripheral embolism, an obstruction of the blood supply to an organ. Anticoagulation therapies, such as Warfarin, are well known to substantially reduce the risk of atrial fibrillation-related stroke and embolism, but also have been shown to increase the risk for hemorrhage. "Because of this increased hemorrhage risk, physicians are sometimes hesitant to prescribe the drug, and some studies have shown that women are less likely to receive warfarin therapy than men," Fang said. "However, we found that women in our study did not suffer bleeding complications related to Warfarin more often than men who were using the therapy."

Furthermore, data showed that women may actually benefit more from Warfarin because of their higher baseline risk for stroke. "Women with atrial fibrillation, particularly those with other risk factors for stroke, should be especially encouraged to take Warfarin," Fang added.

Vanessa deGier | EurekAlert!
Further information:
http://www.ucsf.edu

More articles from Health and Medicine:

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

nachricht How to turn white fat brown
07.12.2016 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>